From SYNTAX to FAME, a paradigm shift in revascularization strategies: The key role of fractional flow reserve in guiding myocardial revascularization

Journal of Cardiovascular Medicine

Volumn 12, Issue 8, 2011, Pages 538-542

  Mangiacapra, Fabio ^a   Barbato, Emanuele ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DRUG ELUTING STENT; FRACTIONAL FLOW RESERVE; FRACTIONAL FLOW RESERVE VERSUS ANGIOGRAPHY FOR MULTIVESSEL EVALUATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; SURVIVAL; SYNERGY BETWEEN PERCUTANEOUS CORONARY INTERVENTION WITH TAXUS AND CARDIAC SURGERY; TREATMENT OUTCOME;

CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79960924751     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328347edc3     Document Type: Review

References (21)

1. Bugiardini R, Bairey Merz CN. Angina with normal coronary arteries: a changing philosophy. JAMA 2005; 293:477-484.
2. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004; 11:171-185. (Pubitemid 38949912)
3. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107:2900-2907.
4. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 2008; 300:1765-1773.
5. Wijns W, De Bruyne B, Vanhoenacker PK. What does the clinical cardiologist need from noninvasive cardiac imaging: is it time to adjust practices to meet evolving demands? J Nucl Cardiol 2007; 14:366-370. (Pubitemid 46840311)
6. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360:961-972.
7. Gerber RT, Ielasi A, Al-Lamee R, et al. Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score. Cardiovasc Revasc Med 2011 (in press).
8. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study. Fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010; 55:2816-2821.
9. Mangiacapra F, De Bruyne B, MullerO, et al. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2010; 3:35-40.
10. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87:1354-1367. (Pubitemid 23110406)
11. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995; 92:39-46.
12. Pijls NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92:3183-3193.
13. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334:1703-1708. (Pubitemid 26193622)
14. Mangiacapra F, Di Serafino L, Barbato E. The role of fractional flow reserve to guide stent implantation. Minerva Cardioangiol 2011; 59:39-48.
15. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year followup of the DEFER study. J Am Coll Cardiol 2007; 49:2105-2111. (Pubitemid 46771047)
16. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997; 95:2037-2043. (Pubitemid 27184271)
17. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007; 297:1985-1991. (Pubitemid 46740350)
18. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213-224.
19. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010; 56:177-184.
20. Fearon WF, Bornschein B, Tonino PA, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010; 122:2545-2550.
21. Boden WE, ORourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-1516. (Pubitemid 46588415)